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Trifocal choroidal melanoma in an
eye with oculodermal melanocytosis:
A case report
Samuel J Fallon1, Charlotte N Shields1,
Maura Di Nicola1,2
We report a case of trifocal choroidal melanoma (three separate
tumors) in a 48‑year‑old Caucasian female who had been
followed for oculodermal melanocytosis since childhood. At
presentation, no tumor was present and annual examination
was advised. Seventeen years later, three choroidal melanocytic
lesions were detected in the right eye. Growth of each was
documented, enucleation was performed, and histopathology
revealed three independent choroidal melanomas. The patient
developed extensive liver and bone metastases and subsequently
died. Oculodermal melanocytosis is a risk factor for the
development of uveal melanoma and a potential marker for
worse prognosis. Careful long‑term follow‑up is required.
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Congenital oculodermal melanocytosis is a well‑known
condition characterized by patchy periocular cutaneous,
episcleral, uveal, orbital, meningeal, and palate pigmentation.[1]
This condition can lead to uveal melanoma, estimated to occur
1 in 400 affected Caucasians,[2] and melanoma of the ipsilateral
orbit and meninges.[1] Patients with ocular melanocytosis and
uveal melanoma typically manifest a more fulminant disease
with twice greater risk for metastasis compared to those
without melanocytosis.[3]
Typically, choroidal melanoma manifests as a unilateral
and unifocal tumor.[4] Honavar et al. reported in 2002 that
only 19 cases of multifocal uveal melanoma had been
recorded over approximately 120 years and nearly all were
bifocal (two melanomas in an eye).[4] Trifocal melanoma is
exceedingly rare. A PubMed search for <trifocal> <melanoma>
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<eye> and <uvea> revealed only one published case of a patient
displaying bifocal melanoma in an eye and unifocal melanoma
in the contralateral eye. [5] Multifocal uveal melanoma is
typically associated with ocular melanocytosis, but can be
related to BAP‑1 cancer predisposition syndrome.[6,7] It has
been estimated that Caucasian individuals with unilateral
multifocal melanoma have a thousandfold greater chance of
demonstrating ocular melanocytosis.[4] To our knowledge,
we describe the first case of three separate melanomas in an
eye in a patient with underlying ocular melanocytosis since
childhood.

Case Report
In July 1986, a 48‑year‑old Caucasian female was referred
for evaluation of pigmentation on both eyes (OU), which
was present since childhood [Fig. 1]. Best corrected visual
acuity was 20/20 OU and intraocular pressures were normal
OU. Full‑face evaluation revealed bilateral blue dermal
pigmentation on the temporal scalp and slight pigmentation
on the palate was noted. Ophthalmic examination showed
diffuse bilateral scleral pigmentation and choroidal darkening
and thickening were noted OU. There was no sign of uveal
melanoma. Oculodermal melanocytosis was diagnosed, and
yearly follow‑up was advised.
The patient remained stable until October 2002, when a
flat amelanotic lesion measuring 2 × 1.5 mm in basal diameter
and 1.5 mm in thickness was noted superotemporally in the
right eye (OD). In 2003, a new pigmented choroidal lesion was
noted inferotemporally OD, measuring 3.5 × 3.5 mm in basal
diameter and 2.5 mm in thickness. In 2005, a third pigmented
lesion was found inferonasally OD, measuring 3 × 3 mm in basal
diameter and 2.7 mm in thickness. Treatment was discussed,
but patient preferred close follow‑up [Fig. 2a]. Systemic
work‑up including physical examination, liver function tests,
and CT scan of abdomen and chest were advised to rule out
malignancy elsewhere in the body.
Eight months later, all three tumors enlarged [Fig. 2b],
suggesting multifocal choroidal melanoma. Conservative
management with plaque radiotherapy and thermotherapy
were discussed, but the patient preferred enucleation. Genetic
testing for cytogenetics and BAP‑1 predisposition syndrome
was not performed as it was not routinely available in our
practice at the time of treatment.
Histopathology of the globe revealed congenital oculodermal
melanocytosis and three distinct choroidal melanomas,
including mixed cell type (inferotemporally and inferonasally)
and low‑grade spindle cell type (superotemporally) [Fig. 3].
Oculodermal melanocytosis with scattered dendritic
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Figure 2: Slow enlargement of three melanomas in an eye with uveal
melanocytosis. (a) In 2005, three thin choroidal tumors were noted
superotemporally, inferotemporally, and inferonasally, all with bland
features. (b) Eight months later, all three tumors showed enlargement
b

c

Figure 1: Bilateral scleral melanoctosis. (a) External photograph
demonstrating minimal periocular dermal pigmentation, but there was
dark blue temporal fossa pigmentation and there was diffuse episcleral
melanocytosis of the right (b) and the left (c) eyes
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Figure 3: Histopathology of each tumor. (a and b) The inferonasal
melanoma demonstrated mixed cell type and 14 mitotic figures in
40 high‑power fields (HPF). (c and d) The inferotemporal melanoma
revealed mixed cell type and 1 mitotic figure in 40 HPF. (e and f) The
superotemporal melanoma demonstrated mixed cell, predominantly
spindle type and no mitotic figure in 40 HPF

melanocytes in the epibulbar surface, moderate amount of
pigment in the iris and ciliary body stroma, thickened and
intensely pigmented choroidal stroma, and discrete foci
of melanocytes in the posterior sclera was confirmed on
histopathology.
In December 2008, metastatic melanoma to the liver and
later bone was detected, leading to death within one month.

Discussion
Congenital oculodermal melanocytosis is characterized by
excessive melanocytes in the periocular region involving the
skin, sclera, uvea, orbit, meninges, palate, and/or tympanic
membrane.[1,3] This condition carries risk for the development
of ipsilateral glaucoma, related to trabecular meshwork
pigmentation, as well as uveal melanoma, related to uveal
pigmentation.[1] It has been estimated that the lifetime risk for
a single uveal melanoma in an, otherwise, healthy Caucasian
is 1 in 13,000, compared to 1 in 400 in a Caucasian with ocular
melanocytosis.[2] The calculated rate of two melanomas in
a Caucasian with melanocytosis would be 1 in 160,000 and
three melanomas in the same scenario would be 1/64,000,000,
presuming all are independent of each other.[2,4]
Recent data have suggested that ocular melanocytosis, a
sporadic condition, is related to a somatic mutation of GNAQ,
a heterotrimeric G protein alpha subunit.[8] This mutation
is found in blue nevus (83%), uveal melanoma (46%), and
oculodermal melanocytosis (6%).[8] Thomas et al. studied skin
biopsies of cutaneous melanocytosis in six cases and found
GNAQ/GNA11 mutations in three (50%).[9] Tse et al. reported
transformation of dermal melanocytosis into melanoma
and documented both GNAQ and BAP‑1 mutations.[10] Our
patient did not have genetic testing as these associations
were discovered after her management, but we speculate that
GNAQ/GNA11 somatic mutation could have been present.
Outcomes regarding metastases in patients with choroidal
melanoma arising from oculodermal melanocytosis has
revealed a 1.6 times greater metastatic risk compared
to individuals without oculodermal melanocytosis. [3]
By Kaplan–Meier analysis, metastatic risk in those with
melanoma and melanocytosis was 2% at one year, 27% at
five years, and 48% at ten years.[3] Our patient developed
metastatic disease to the liver three years following therapy
for the trifocal melanoma.
A review of the published literature has revealed one case of
trifocal melanoma affecting two eyes and no cases in an eye.[5] In
the bilateral case, Lois et al. described a patient without ocular
melanocytosis who developed trifocal melanoma involving
both eyes in sequential fashion. Two years after treatment, the
patient remained alive without metastatic disease. Without
evidence of melanocytosis, this patient could have had
underlying BAP1 tumor predisposition syndrome or a yet
undiscovered germline cancer mutation.[6,7]
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Conclusion
In conclusion, our case illustrates an exceedingly rare
combination of ocular melanocytosis with three independent
melanomas in an eye, which has not been previously described.
Interestingly, the patient was followed for 16 years before the
choroidal lesions were noted and subsequently developed
into melanoma over 2 years. We advise all patients with
oculodermal melanocytosis to have twice yearly evaluation
and prompt intervention if malignancy is detected.
Declaration of patient consent
The authors certify that they have obtained all appropriate
patient consent forms. In the form, the patient(s) has/have
given his/her/their consent for his/her/their images and other
clinical information to be reported in the journal. The patients
understand that their names and initials will not be published
and due efforts will be made to conceal their identity, but
anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.

References
1.

Shields JA, Shields CL. Intraocular Tumors: An Atlas and Textbook.
3rd ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2016.

Bilateral diffuse uveal melanocytic
proliferation secondary to thyroid
carcinoma
Vishal Raval, Avinash Pathengay1,
Raja Narayanan2

Access this article online
Quick Response Code:

Website:
www.ijo.in
DOI:
10.4103/ijo.IJO_445_19
PMID:
*****

Retina and Vitreous Services, L V Prasad Eye Institute,
Vijayawada, 1Retina and Vitreous Services, L V Prasad Eye Institute,
Vishakapatnam, Andhra Pradesh, 2Retina and Vitreous Services, L V
Prasad Eye Institute, Hyderabad, Telangana, India
Correspondence to: Dr. Raja Narayanan, Retina and Vitreous Services,
L V Prasad Eye Institute, KAR Campus, Hyderabad ‑ 500 034,
Telangana, India. E‑mail: narayanan@lvpei.org
Received: 05-Mar-2019
Accepted: 03-Jun-2019

Revision: 28-May-2019
Published: 22-Nov-2019

Volume 67 Issue 12

2.

Singh AD, De Potter P, Fijal BA, Shields CL, Shields JA, Elston RC.
Lifetime prevalence of uveal melanoma in white patients with
oculo (dermal) melanocytosis. Ophtahlmology 1998;105:195‑8.

3.

Shields CL, Kaliki S, Livesey M, Walker B, Garoon R, Bucci M, et al.
Association of ocular and oculodermal melanocytosis with the rate
of uveal melanoma metastasis. Analysis of 7872 consecutive eyes.
JAMA Ophthalmol 2013;131:993‑1003.

4.

Honavar SG, Shields CL, Singh AD, Demirci H, Rutledge BK,
Shields JA, et al. Two discrete choroidal melanomas in an eye with
ocular melanocytosis. Surv Opthalmol 2002;47:36‑41.

5.

Lois N, Shields CL, Shields JA, De Potter P, Ramsey MS. Trifocal
uveal melanoma. Am J Ophthalmol 1997;124:848‑50.

6.

Rao R, Pointdujour‑Lim R, Ganguly A, Shields CL. Multifocal
choroidal melanoma in a patient with germ line BRCA‑associated
protein 1 mutation. Retin Cases Brief Rep 2016;12:1‑4.

7.

Masoomian B, Shields JA, Shields CL. Overview of BAP1 cancer
predisposition syndrome and the relationship to uveal melanoma.
J Curr Ophthalmol 2018;30:102‑9.

8.

Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L,
O’Brien JM, et al. Frequent somatic mutations of GNAQ in uveal
melanoma and blue naevi. Nature 2009;457:599‑602.

9.

Thomas AC, Zeng Z, Riviere JB, O’Shaughnessy R, Al‑Olabi L,
St‑Onge J, et al. Mosaic activating mutations in GNA11 and
GNAQ are associated with phakomatosis pigmentovascularis and
extensive dermal melanocytosis. J Invest Dermatol 2016;136:770‑8.

10. Tse JY, Walls BE, Pomerantz H, Yoon CH, Buchbinder EI,
Werchniak AE, et al. Melanoma arising in a nevus of Ito: Novel
genetic mutations and a review of the literature on cutaneous
malignant transformation of dermal melanocytosis. J Cut Pathol
2016;43:57‑63.

We present a rare case of a bilateral diffuse uveal melanocytic
proliferation (BDUMP), which occurred secondary to recurrence
of carcinoma of thyroid in a 79‑year‑old gentleman who was
initially misdiagnosed to have age related macular degeneration
and/or chronic central serous chorioretinopathy. In spite of being
treated with anti‑VEGF injection and photodynamic therapy
there was progressive loss of vision. Multimodal imaging like
autoflourescence, infrared imaging, fluorescein angiography,
indocyanine angiography, and OCT angiography helped us in
clinching the final diagnosis.
Key words: Bilateral diffuse uveal melanocytic proliferation,
infrared imaging, paraneoplastic syndrome, thyroid
carcinoma

Bilateral diffuse uveal melanocytic proliferation (BDUMP)
is a rare paraneoplastic neoplasm first described in 1966
by Machemer.[1] It is characterized by multiple, elevated
pigmented chorioretinal lesions, rapidly progressive cataracts,
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